Lee Namju, Park Sok, Kim Jongkyu
Department of Sports Medicine, School of Arts & Sports Science, Jungwon University, Chungbuk, Republic of Korea.
Department of Sports and Health Management, Mokwon University, Daejeon, Republic of Korea.
J Exerc Nutrition Biochem. 2015 Jun;19(2):115-21. doi: 10.5717/jenb.2015.15061209. Epub 2015 Jun 30.
The purpose of this study was to examine the effects of hippotherapy on brain function and levels of blood-derived neurotrophic factor (BDNF) in children with attention deficit and/or hyperactivity disorder (ADHD).
The hippotherapy group (HRG) included twenty children with ADHD and the control group (CG) included 19 children. All participants' physical fitness, fMRI brain scans, and blood BDNF levels were measured at baseline and after 32 weeks of participating in hippotherapy.
After 32 weeks of participating in hippotherapy, the body fat of the HRG was significantly decreased (-1.12 ± 4.20%) and the body fat of the CG was increased (2.38 ± 6.35%) (p=0.049). There was no significant difference of physical fitness in both groups (p>0.05). Although there was a higher decrease in the activated insular area in the HRG (-1.59 ± 0.99) than in the CG (-1.14 ± 1.41), there was no significant difference between the two groups (p>0.05) Also, there was a higher increase in the activated cerebellum area in the HRG (1.97 ± 1.45) than in the CG (1.92 ± 1.81). However, there was no significant difference between the two groups (p>0.05). BDNF levels showed an increased tendency in the HRG (166.29 ± 277.52pg) compared to the CG (21.13 ± 686.33pg); otherwise, there was not any significant difference in these blood levels between the two groups (p>0.05). It can be assumed that big individual differences in the level of ADHD in the study participants might not cause any significant results, although there might be positive changes in the brain function of children with ADHD.
Therefore, this study suggests that hippotherapy training would need to be modified and developed to increase the efficacy of hippotherapy in children with ADHD.
本研究旨在探讨马术疗法对注意力缺陷和/或多动障碍(ADHD)儿童脑功能及血液源性神经营养因子(BDNF)水平的影响。
马术疗法组(HRG)包括20名ADHD儿童,对照组(CG)包括19名儿童。在基线期以及参与马术疗法32周后,对所有参与者的身体素质、功能磁共振成像(fMRI)脑部扫描及血液BDNF水平进行测量。
参与马术疗法32周后,HRG组的体脂显著降低(-1.12±4.20%),而CG组的体脂增加(2.38±6.35%)(p=0.049)。两组的身体素质无显著差异(p>0.05)。尽管HRG组激活的脑岛区域下降幅度(-1.59±0.99)高于CG组(-1.14±1.41),但两组之间无显著差异(p>0.05)。此外,HRG组激活的小脑区域增加幅度(1.97±1.45)高于CG组(1.92±1.81)。然而,两组之间无显著差异(p>0.05)。与CG组(21.13±686.33pg)相比,HRG组的BDNF水平呈上升趋势(166.29±277.52pg);否则,两组的这些血液水平无任何显著差异(p>0.05)。可以推测,尽管ADHD儿童的脑功能可能有积极变化,但研究参与者中ADHD水平的巨大个体差异可能不会导致任何显著结果。
因此,本研究表明,需要对马术疗法训练进行改进和完善,以提高其对ADHD儿童的疗效。